Skip to main content

Bratton Capital Management, L.P.

13F filer · CIK 0001723787
Reported Aug 11, 2026
13F portfolio value$40.8MU.S. long equity reported on 13F
Positions10 new · 0 closed
Net flow last quarter$0Buys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 11, 20261 positions
AQSTAquestive Therapeutics, Inc.$40.8M100.00%7.82%Not reportedQ4 2018
Q1 2026Reported May 13, 20261 positions
AQSTAquestive Therapeutics, Inc.$40.7M100.00%7.89%Not reportedQ4 2018
Q4 2025Reported Feb 17, 20261 positions
AQSTAquestive Therapeutics, Inc.$63.4M100.00%8.04%Not reportedQ4 2018
Q3 2025Reported Nov 14, 20251 positions
AQSTAquestive Therapeutics, Inc.$54.8M100.00%8.06%Not reportedQ4 2018
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.